Over the last 7 days, the Biotech industry has remained flat, although notably Moderna declined by 14%. As for the the longer term, the industry is up 5.5% over the past 12 months. Looking forward, earnings are forecast to grow by 25% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 02 Jun 2024 | US$1.1t | US$164.6b | -US$26,677,143,877.65 | 27.4x | -42.1x | 6.8x |
Tue, 30 Apr 2024 | US$1.1t | US$164.6b | -US$27,374,440,770.81 | 22.8x | -39.1x | 6.5x |
Thu, 28 Mar 2024 | US$1.2t | US$164.4b | -US$23,823,048,661.67 | 21.5x | -49.4x | 7.2x |
Sat, 24 Feb 2024 | US$1.2t | US$166.7b | -US$21,620,417,137.21 | 10.8x | -54.5x | 7.1x |
Mon, 22 Jan 2024 | US$1.4t | US$204.8b | -US$22,505,807,764.00 | 18.5x | -63.4x | 7x |
Wed, 20 Dec 2023 | US$1.4t | US$204.8b | -US$22,154,151,632.00 | 19.6x | -61.2x | 6.6x |
Fri, 17 Nov 2023 | US$1.2t | US$204.7b | -US$22,125,754,712.00 | 16.5x | -54.7x | 5.9x |
Sun, 15 Oct 2023 | US$1.3t | US$207.3b | -US$13,137,172,262.00 | 16.6x | -96.4x | 6.1x |
Tue, 12 Sep 2023 | US$1.3t | US$207.6b | -US$12,635,687,518.00 | 17.5x | -101.7x | 6.2x |
Thu, 10 Aug 2023 | US$1.3t | US$207.7b | -US$12,585,104,613.00 | 16.7x | -101.4x | 6.1x |
Sat, 08 Jul 2023 | US$1.1t | US$186.3b | -US$16,022,507,026.00 | 12.9x | -69.1x | 5.9x |
Mon, 05 Jun 2023 | US$1.1t | US$185.9b | -US$16,012,816,022.00 | 11.4x | -71.1x | 6.1x |
Wed, 03 May 2023 | US$1.2t | US$197.5b | -US$6,736,968,452.00 | 14.4x | -171.8x | 5.9x |
Fri, 31 Mar 2023 | US$1.1t | US$198.6b | -US$3,738,200,739.00 | 13.9x | -303.7x | 5.7x |
Sun, 26 Feb 2023 | US$1.1t | US$200.5b | -US$3,797,679,065.00 | 14.2x | -295.4x | 5.6x |
Tue, 24 Jan 2023 | US$1.2t | US$203.8b | US$1.8b | 14.7x | 665x | 5.7x |
Thu, 22 Dec 2022 | US$1.2t | US$203.3b | US$1.6b | 14.6x | 711.6x | 5.7x |
Sat, 19 Nov 2022 | US$1.1t | US$202.2b | US$1.2b | 14.7x | 916.1x | 5.6x |
Mon, 17 Oct 2022 | US$1.0t | US$206.0b | US$5.4b | 15.6x | 194.3x | 5.1x |
Wed, 14 Sep 2022 | US$1.1t | US$206.9b | US$5.9b | 15.8x | 185.7x | 5.3x |
Fri, 12 Aug 2022 | US$1.1t | US$207.0b | US$7.7b | 15.9x | 143.3x | 5.3x |
Sun, 10 Jul 2022 | US$1.1t | US$211.5b | US$10.8b | 17.4x | 102.3x | 5.2x |
Tue, 07 Jun 2022 | US$990.4b | US$212.7b | US$11.3b | 16x | 87.8x | 4.7x |
Thu, 05 May 2022 | US$1.0t | US$201.2b | US$7.4b | 17.7x | 140.4x | 5.2x |
Sat, 02 Apr 2022 | US$1.3t | US$227.1b | US$14.3b | 19.1x | 90.8x | 5.7x |
Mon, 28 Feb 2022 | US$1.2t | US$222.9b | US$10.9b | 19.5x | 113.3x | 5.5x |
Wed, 26 Jan 2022 | US$1.2t | US$211.9b | US$2.4b | 23x | 507.2x | 5.8x |
Fri, 24 Dec 2021 | US$1.4t | US$212.0b | US$2.8b | 27.7x | 518.2x | 6.8x |
Sun, 21 Nov 2021 | US$1.5t | US$212.1b | US$3.3b | 27.1x | 448.1x | 6.9x |
Tue, 19 Oct 2021 | US$1.5t | US$196.3b | -US$2,600,461,581.00 | 23.3x | -560.5x | 7.4x |
Thu, 16 Sep 2021 | US$1.6t | US$196.2b | -US$2,352,567,480.56 | 20.8x | -673.3x | 8.1x |
Sat, 14 Aug 2021 | US$1.6t | US$197.0b | -US$1,662,914,785.58 | 22.7x | -936x | 7.9x |
Wed, 09 Jun 2021 | US$1.4t | US$174.8b | -US$11,505,542,875.55 | 22.2x | -120.4x | 7.9x |
-120.4x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -0.62% | |
Healthcare | -0.65% | |
Biotech | -0.37% | |
Biotech | -0.37% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ABBV AbbVie | US$161.24 | 2.7% +US$7.4b | 17.8% | PE47.8x | |
INSM Insmed | US$55.05 | 150.2% +US$5.6b | 181.7% | PS28.1x | |
SMMT Summit Therapeutics | US$8.69 | 157.0% +US$3.7b | 379.8% | PB137.9x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
GRPH Graphite Bio | US$22.26 | 539.7% +US$1.1b | 861.6% | PB7.1x |